AbbVie Deutschland GmbH and Co KG has a total of 13 patent applications. Its first patent ever was published in 2010. It filed its patents most often in Peru, China and Philippines. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and measurement are UCB PHARMA S A, IDUN PHARMACEUTICALS INC and ICOS CORP.
# | Country | Total Patents | |
---|---|---|---|
#1 | Peru | 9 | |
#2 | China | 3 | |
#3 | Philippines | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Measurement | |
#4 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Heterocyclic compounds | |
#3 | Medical preparations | |
#4 | Organic chemistry methods | |
#5 | Peptides | |
#6 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Drescher Karla | 6 |
#2 | Jantos Katja | 4 |
#3 | Ochse Michael | 4 |
#4 | Geneste Herve | 4 |
#5 | Helmut Mack | 3 |
#6 | Jakob Clarissa | 3 |
#7 | Dinges Jurgen | 3 |
#8 | Hannes Koolman | 2 |
#9 | Huang Lili | 2 |
#10 | Relo Ana-Lucia | 2 |
Publication | Filing date | Title |
---|---|---|
CN104418862A | Tricyclic chinoline and quinoxaline derivatives |